
Heartburn drug makers hid cancer risk for over 40 years before they silently began to withdraw the cancer-inducing drug from the market.

British pharmaceutical giant Glaxo has been hiding the dangers of its stomach ulcer and heartburn drug Zantac for more than 40 years. It is reported by Bloomberg. The agency found that the manufacturer had been aware since 1978 (45 years) of the property of the active ingredient in ranitidine to release the powerful cancer-causing agent N-nitroso dimethylamine (NDMA) in the body.

However, despite this, the company hid the results of these studies and did not recall the drug from pharmacies.
The general public was only informed about the dangers of ranitidine in 2019. Then and reluctantly, incredibly, only after that, Zantac manufacturers and health regulators around the world began to recall the highly profitable killer drug.

At the same time, pharmacists claim that the increased risk of cancer when taking Zantac has not been scientifically proven and such assumptions are speculative.
Zantac was the most popular prescription drug. These days, NDMA is being used to induce cancer in lab rats.

Some stars use alternative medicine methods instead of drugs. Who prefers this type of treatment? Find out in the gallery: If you care you should share this story on social media.

Categories: Uncategorized

















Latest Zantac Lawsuit Settlements
Under private Zantac lawsuit settlement agreements, GSK said it will pay up to $2.2 billion to resolve approximately 80,000 Zantac lawsuits.
The settlement agreements announced in October 2024 apply to 93% of the Zantac lawsuits filed in state court. As of October 2025, 2,233 federal Zantac lawsuits were still pending in a multidistrict litigation in the U.S. District Court for the Southern District of Florida.
GSK had settled multiple cases confidentially earlier in 2024. Another manufacturer, Sanofi, agreed to pay between $200 million and $250 million to settle more than 10,000 Zantac lawsuits in May 2024. Before that, in April, 2024, Sanofi had offered $100 million to settle 4,000 Zantac lawsuits.
As of July 2026, there are still 847 pending lawsuits out of 15,018 cases from all across the country originally filed in multidistrict litigation in Florida.
Drugwatch’s legal partners are no longer accepting Zantac cases.
I am sure in EUROPA there is also law suit on going and around the globe.
LikeLike